Dr. Kimberly E. Resnick
Claim this profileMetroHealth Medical Center
Area of expertise
Ovarian Cancer
Kimberly E. Resnick has run 4 trials for Ovarian Cancer. Some of their research focus areas include:
Cervical Cancer
Kimberly E. Resnick has run 3 trials for Cervical Cancer. Some of their research focus areas include:
Affiliated Hospitals
MetroHealth Medical Center
Clinical Trials Kimberly E. Resnick is currently running
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
Surgical Procedures
for Reducing Ovarian Cancer Risk
This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting
1 award
N/A
More about Kimberly E. Resnick
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kimberly E. Resnick has experience with
- Paclitaxel
- Cisplatin
- Carboplatin
- AGEN2034
- AGEN1884
- Topotecan
Breakdown of trials Kimberly E. Resnick has run
Ovarian Cancer
Cervical Cancer
Fallopian Tube Cancer
Cervical Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kimberly E. Resnick specialize in?
Kimberly E. Resnick focuses on Ovarian Cancer and Cervical Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are Stage II.
Is Kimberly E. Resnick currently recruiting for clinical trials?
Yes, Kimberly E. Resnick is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Kimberly E. Resnick has studied deeply?
Yes, Kimberly E. Resnick has studied treatments such as Paclitaxel, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Kimberly E. Resnick?
Apply for one of the trials that Kimberly E. Resnick is conducting.
What is the office address of Kimberly E. Resnick?
The office of Kimberly E. Resnick is located at: MetroHealth Medical Center, Cleveland, Ohio 44109 United States. This is the address for their practice at the MetroHealth Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.